Financial Performance - GAAP gross revenue reached $2.9 billion, a 2.2% year-over-year increase, while adjusted net revenue was $2.1 billion, up 3.1% year-over-year[10] - GAAP net income was $11 million, a decrease of 87.9% year-over-year, but adjusted net income increased by 18.8% to $176 million[10] - Adjusted EBITDA increased by 8.1% year-over-year to $287 million, with an adjusted EBITDA margin of 13.4% on adjusted net revenue[10] - GAAP EPS was $0.10, down 86.3% year-over-year, while adjusted EPS increased by 22.2% to $1.43[10] Infrastructure and Advanced Facilities (I&AF) Segment - I&AF backlog increased to $21.768 billion[35] - I&AF operating profit was $203 million, a decrease of 0.4% year-over-year, with an operating profit margin of 11.1% of adjusted net revenue[23] - Water & Environmental adjusted net revenue was $542 million, a decrease of 1.7% year-over-year[18] - Critical Infrastructure adjusted net revenue was $907 million, an increase of 2.2% year-over-year[20] - Life Sciences & Advanced Manufacturing adjusted net revenue was $382 million, an increase of 5.8% year-over-year[18] Balance Sheet and Cash Flow - Net debt stood at $1.4 billion with a net debt to LTM adjusted EBITDA ratio of 1.26x[26] - The company repurchased $351 million in shares, a 268% year-over-year increase, and declared a quarterly dividend of $0.32 per share, up 10% year-over-year[24] Fiscal Year 2025 Outlook - The company reaffirmed its FY25 financial targets, including mid-to-high single-digit adjusted net revenue growth year-over-year[27] - The company expects free cash flow conversion to be greater than 100% of net income[28]

Q2 Fiscal 2025 Earnings May 6, 2025 + This document contains both historical and forward-looking statements. Forward-looking statements are not based on historical facts but instead reflect our expectations, estimates or projections concerning future results or events, including, without limitation, the future sales, gross margins, costs, earnings, cash flows, tax rates and performance of the Company. These statements generally can be identified by the use of forward-looking words or phrases such as "believ ...

First Quarter 2025 Earnings Conference Call May 6, 2025 Proprietary business information of ADM. Proprietary business information of ADM. Proprietary business information of ADM. 2 Cautionary Note Regarding Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact included in this presentation, are forwa ...

Financial Performance - Adjusted EBITDA increased by 7% year-over-year to $1.8 billion[7,9] - Distributable cash flow (DCF) increased by 8% year-over-year[31] - Distributions to unitholders totaled $978 million[7] - Unit repurchases amounted to $100 million[7] - Adjusted free cash flow was $641 million[31] - Total capital returned to unitholders was $1.078 billion[31] Strategic Investments and Growth - Over $1 billion of bolt-on acquisitions were announced[9] - MPLX acquired the remaining 55% interest in BANGL, LLC for $715 million[7] - A crude gathering system was acquired for $237 million[7] - An additional 5% interest in the Matterhorn Express Pipeline joint venture was acquired for $151 million[7] - The company plans to expand the BANGL pipeline to 300 thousand barrels per day (MBPD)[15] Operational Highlights - Crude oil pipeline volume was 3.9 million barrels per day (MMBPD), a 13% increase[26] - Product pipeline volume was 2.0 MMBPD, a 10% increase[26] - Terminal volume was 3.1 MMBPD, a 6% increase[26] - Natural gas gathering volume was 6.5 billion cubic feet per day (Bcf/d), a 5% increase[27] - Natural gas processing volume was 9.8 Bcf/d, a 4% increase[27] - Fractionation volume was 660 MBPD, a 4% increase[27]

Company Overview - Limbach specializes in revitalizing and maintaining mission-critical systems in existing facilities [5] - The company has approximately 1,400 team members and operates across 20 branch locations [11, 13] - Limbach focuses on six distinct vertical markets to diversify revenue streams [18] Financial Performance and Strategy - From FY 2019 to FY 2024, Limbach expanded its gross margin by nearly 1,480 bps to 27.8%, driving Adjusted EBITDA Margin more than 4x from 3.0% to 12.3% [33] - The company targets a shift in revenue mix to approximately 80% ODR (Owner Direct Relationships) and approximately 20% GCR (General Contractor Relationships) [32] - Limbach projects total revenue between $610 million and $630 million for 2025, with ODR revenue growth between 23% and 46% [62] - The company anticipates an Adjusted EBITDA between $78 million and $82 million in 2025, resulting in an Adjusted EBITDA Margin between 12.5% and 13.5% [62] Acquisitions and Expansion - Consolidated Mechanical is expected to contribute approximately $23 million in annualized revenue and $4 million in EBITDA beginning in 2025 [53] - Kent Island Mechanical is expected to contribute on average $30 million in revenue and $4 million in EBITDA on a full year basis [59] Q1 2025 Performance - Limbach reported revenue of $133.1 million in Q1 2025, an increase of 11.9% year-over-year [69] - Gross profit for Q1 2025 was $36.7 million, with a gross margin of 27.6% [69] - Adjusted EBITDA for Q1 2025 was $14.9 million, compared to $11.8 million in Q1 2024 [70]

Company Overview - Vitesse's assets are comprised of over 80% undeveloped locations, indicating a long-term growth potential[8, 27] - Vitesse estimates having over 200 net remaining undeveloped locations across its asset[15, 18] - Vitesse has interests in 7,397 productive wells (221 net wells) with an average working interest of 3.6% per working interest well[18] Financial Performance & Strategy - Vitesse estimates 2025 net production to be 15.0 – 17.0 MBoe/d with 64-68% oil weighting[15] - Vitesse offers an 11% fixed dividend yield[8] - Vitesse has a returns-based capital allocation framework, including a $0.5625 per share quarterly cash dividend and a $60 million share repurchase program[10] - Vitesse targets a net debt to adjusted EBITDA ratio of less than 1.0x[10, 27] Asset Valuation - Vitesse's 1P PV-10 is $806 million, and PDP PV-10 is $609 million[15] - Vitesse has nearly 200 acquisitions and divestitures totaling $757 million[27]

FIRST QUARTER 2025 EARNINGS PRESENTATION May 6, 2025 Use of non-GAAP financial measures: This presentation includes certain non‐GAAP financial measures intended to supplement, not substitute for, comparable GAAP measures. Reconciliations of non‐GAAP financial measures to GAAP financial measures are provided within the Appendix to this presentation. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. The company does not attempt to provid ...

Earnings Presentation Q1 2025 May 6, 2025 2025 DigitalOcean. All rights reserved Safe Harbor The statements in the presentation regarding our financial outlook are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause actual results or outcomes to be materially different from any future r ...

SUPPLEMENTAL MATERIALS First Quarter 2025 Quarter Ended March 31, 2025 SUPPLEMENTAL MATERIALS Important Information This presentation contains forward-looking statements. All statements other than statements of historical fact contained in this presentation, including our expectations regarding future expected revenue growth and free cash flow, are forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions that may prove incorrect, any of whi ...

Financial Performance - Total revenue reached $65 million, reflecting a 63% increase adjusting for a one-time settlement agreement milestone received in Q1 2024[9] - U S net product sales grew by 41% to $34 9 million[10] - Collaboration revenue was $30 1 million[34] Prescription Trends - Q1 2025 script growth increased by 2% compared to Q4 2024[15, 16] - Early Q2 2025 prescription volume is tracking approximately 8% higher than Q1 2025[16] Market Access and Clinical Validation - The company tripled the U S field reimbursement team to 15 specialists[12] - Over 30 major healthcare plans removed prior authorizations and expanded formulary coverage for NEXLETOL and NEXLIZET[12] Global Expansion - Products are approved in 40 countries globally[21] - Approximately 472,500 patients have been reached internationally through February 2025[24] Pipeline Development - The company is developing a triple combination product with an estimated LDL-C reduction of approximately 60%-70%[19] - A program targeting Primary Sclerosing Cholangitis (PSC) is in development, with an IND planned for 2026, addressing a market opportunity estimated at over $1 billion annually[27, 30]